ARTICLE | Company News
BTG, Collegium asthma deal
August 30, 2005 12:51 AM UTC
BTG (LSE:BGC) and Collegium ( Cumberland, R.I.) partnered to develop CP-141, an extended-release oral formulation of an undisclosed, approved asthma drug. The deal combines Collegium's formulation tec...